Hypertension News and Research RSS Feed - Hypertension News and Research

Left ventricular tissue phase mapping predicts PAH outcomes

Left ventricular tissue phase mapping predicts PAH outcomes

A tissue phase mapping study shows that left ventricular function is abnormal in patients with pulmonary arterial hypertension and is linked to clinical outcomes. [More]
Ambrisentan avoids sildenafil drug interaction in PAH patients

Ambrisentan avoids sildenafil drug interaction in PAH patients

Sildenafil may be better given to pulmonary arterial hypertension patients in combination with ambrisentan than with bosentan, study findings suggest. [More]
Using BMI to measure health incorrectly labels over 54 million Americans as 'unhealthy', study finds

Using BMI to measure health incorrectly labels over 54 million Americans as 'unhealthy', study finds

Over the past few years, body mass index, a ratio of a person's height and weight, has effectively become a proxy for whether a person is considered healthy. Many U.S. companies use their employees' BMIs as a factor in determining workers' health care costs. And people with higher BMIs could soon have to pay higher health insurance premiums, if a rule proposed in April by the Equal Employment Opportunity Commission is adopted. [More]
African-American patients with connective tissue diseases at risk for cardiovascular disease

African-American patients with connective tissue diseases at risk for cardiovascular disease

A study based on medical records from more than a quarter million adult patients found that African-American patients with connective tissue diseases such as lupus or rheumatoid arthritis were twice as likely as white patients to suffer from narrowed or atherosclerotic blood vessels, which increase the risk of a heart attack, stroke or death. [More]
BMPR2 mutations affect outcomes of PAH patients

BMPR2 mutations affect outcomes of PAH patients

Mutations in the bone morphogenetic protein receptor type II gene affect not only the risk of developing pulmonary arterial hypertension but also the severity and outcomes of the disease, shows a meta-analysis of individual patient data. [More]
Study: Young African-Americans often have distorted view of stroke risk

Study: Young African-Americans often have distorted view of stroke risk

Young African-Americans often hold a distorted view of their personal risk for a stroke, two nursing researchers at Georgia State University's Byrdine F. Lewis School of Nursing and Health Professions say in a recently published study in the Journal of Neuroscience Nursing. [More]
Study reveals increased mortality risk following hypertensive disease of pregnancy

Study reveals increased mortality risk following hypertensive disease of pregnancy

In a study to be presented on Feb. 5 at 8 a.m. EST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, in Atlanta, researchers will present findings from a study titled, Long-term mortality risk following hypertensive disease of pregnancy (HDP). [More]
Sleep durations associated with gestational weight gain during in pregnancy

Sleep durations associated with gestational weight gain during in pregnancy

In a study to be presented on Feb. 4 at 1:15 p.m. EST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, in Atlanta, researchers will present findings from a study titled, Short and long sleep durations in pregnancy are associated with extremes of gestational weight gain. [More]
Researchers develop new sensor for continuous monitoring of blood flow in vascular diseases patients

Researchers develop new sensor for continuous monitoring of blood flow in vascular diseases patients

Frequent measurement of blood flow changes could improve the ability of health care providers to diagnose and treat patients with vascular conditions, such as those associated with diabetes and high blood pressure. [More]
FDA-approved blood pressure drug reduces cell damage linked to Alzheimer's disease

FDA-approved blood pressure drug reduces cell damage linked to Alzheimer's disease

In laboratory neuronal cultures, an FDA-approved drug used to treat high blood pressure reduced cell damage often linked to Alzheimer's disease, say researchers at Georgetown University Medical Center and the National Institutes of Health. [More]
Education level influences cognitive training outcomes in older adults

Education level influences cognitive training outcomes in older adults

The first study to investigate the effects of cognitive training on the cognitive functioning of older adults by education level has found that individuals with fewer than 12 years of schooling benefit more from cognitive training than their more highly educated counterparts. [More]

Five centres awarded status of NHS Innovation Test Beds

NHS England has announced the five centres that have been awarded the status of Innovation Test Beds in which new approaches to healthcare provision will be assessed and adopted and two centres for the adoption of the Internet of Things (IoT) in healthcare. [More]
Results from STRIVE trial of enzalutamide versus bicalutamide in CRPC published in Journal of Clinical Oncology

Results from STRIVE trial of enzalutamide versus bicalutamide in CRPC published in Journal of Clinical Oncology

Astellas US LLC, a United States (U.S.) subsidiary of Tokyo-based Astellas Pharma Inc., and Medivation, Inc. today announced that results from the STRIVE trial of enzalutamide compared to bicalutamide in men with castration-resistant prostate cancer (CRPC) were published in the Journal of Clinical Oncology. [More]
Simple blood test could help predict emergence of pre-eclampsia in pregnant women

Simple blood test could help predict emergence of pre-eclampsia in pregnant women

Pre-eclampsia is a serious illness associated with pregnancy, which develops after twenty weeks and is associated with defective ingrowing of the placenta within the mother. The dangerous illness is both the second most frequent cause of death in pregnant women, and the reason for severe complications for mother and child, especially during premature births. [More]
CNIC researchers identify how two proteins control heart growth and adaptation to hypertension

CNIC researchers identify how two proteins control heart growth and adaptation to hypertension

Researchers at the Centro Nacional de Investigaciones Cardiovasculares Carlos III have identified how two proteins control the growth of the heart and its adaptation to high blood pressure (hypertension). [More]
Vascular risk factors implicated in normal pressure hydrocephalus

Vascular risk factors implicated in normal pressure hydrocephalus

Researchers have found that vascular risk factors are associated with idiopathic normal pressure hydrocephalus and could be a possible target for intervention. [More]
Parathyroid hormone may mediate antihypertensive fracture risk

Parathyroid hormone may mediate antihypertensive fracture risk

Parathyroid hormone levels may be elevated by use of some antihypertensive agents but reduced by others, analysis of the Multi-Ethnic Study of Atherosclerosis suggests. [More]
Levels of mitochondrial DNA in the blood may predict chronic kidney disease risk

Levels of mitochondrial DNA in the blood may predict chronic kidney disease risk

The health of blood cells' energy-producing mitochondria may predict a person's risk of developing chronic kidney disease (CKD), according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology. [More]
Aged Garlic Extract beneficial for preventing heart disease

Aged Garlic Extract beneficial for preventing heart disease

The supplement Aged Garlic Extract can reverse the buildup of deadly plaque in arteries and help prevent the progression of heart disease, according to a new study scheduled for publication in the Journal of Nutrition. [More]
Study findings may help explain why risk of stroke changes after menopause

Study findings may help explain why risk of stroke changes after menopause

Risk of stroke in women may come down to a compound the body produces from estrogen known as 2-methoxyestradiol (2-ME). Furthermore, the compound's therapeutic potential may extend beyond treating stroke in women to healing brain injuries in men, a new study in American Journal of Physiology—Endocrinology and Metabolism reports. [More]
Advertisement